Skip to main content

Lonza

ISPE Sets October Washington Summit With Lonza, Lilly CEOs Headlining

ISPE Sets October Washington Summit With Lonza, Lilly CEOs Headlining

North Bethesda, Md. – September 24, 2026 -- The International Society for Pharmaceutical Engineering (ISPE) will convene its 2026 Annual Meeting & Expo in Washington, D.C. from October 18-21, drawing pharmaceutical manufacturing leaders for four days of hybrid sessions combining in-person and virtual attendance.

Lonza and Eli Lilly executives headline keynote lineup on manufacturing innovation

Wolfgang Wienand, PhD, CEO of Lonza, will present "The Lonza Engine: Manufacturing the Medicines of Tomorrow," while Kevin Trivett, Senior Vice President of Device and Packaging Operations Manufacturing at Eli Lilly and Company, delivers "Lilly: Embracing Technology to Reach Patients." Additional featured speakers include Marla Phillips, PhD, CEO and President of Pathway for Patient Health LLC, addressing AI and human oversight in manufacturing loops, and cancer survivor and research advocate Jamie Valvano.

Pharma CDMO Market to Hit $270.3B by 2031, Wissen Research Says

Pharma CDMO Market to Hit $270.3B by 2031, Wissen Research Says

Sheridan – September 11, 2026 -- The global pharmaceutical contract development and manufacturing organization (CDMO) market is forecast to expand from $191 billion in 2026 to $270.3 billion by 2031, a compound annual growth rate of 7.2%, according to a new study by Wissen Research.

Outsourcing and biologics demand drive the growth trajectory

Pharmaceutical and biotechnology firms are increasingly outsourcing drug development and manufacturing to cut capital costs and refocus internal resources on R&D and commercialization. Demand for biologics, biosimilars, cell and gene therapies, antibody-drug conjugates, and mRNA-based medicines is pushing CDMOs to build specialized manufacturing platforms rather than remain peripheral service providers.